|Bid||115.53 x 800|
|Ask||117.50 x 1100|
|Day's range||114.86 - 117.26|
|52-week range||74.75 - 139.55|
|Beta (5Y monthly)||1.13|
|PE ratio (TTM)||126.95|
|Earnings date||07 Feb 2024 - 12 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||124.60|
At present, Charles River (CRL) is the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
In this piece, we will look at the 11 best long-term growth stocks to invest in. If you want to skip our introduction to the current drivers of stock market performance, then check out 5 Best Long term Growth Stocks To Invest In. The year 2023 has proven to be dynamic for the stock market. […]
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.